mHealth Intelligence February 16, 2024
Anuja Vaidya

Virtual care stakeholders have sent a letter asking the DEA to clarify pharmacists’ responsibility regarding virtual prescriptions of controlled substances.

A group of virtual care stakeholders has sent a letter to the United States Drug Enforcement Administration (DEA) urging the agency to provide guidance to the pharmacy community, warning against considering geography a “red flag” when prescriptions are provided during telehealth visits.

The American Telemedicine Association (ATA), its advocacy arm ATA Action, along with virtual care companies Bicycle Health, Circle Medical, DoseSpot, Ophelia, and WorkIt Health, sent the letter on February 12. The companies all offer e-prescriptions for behavioral health and substance abuse disorders.

The letter states that while there are several actions the DEA needs to take to mitigate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth
Related Articles:
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
The telehealth background of Trump's FDA pick: 6 notes
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?

Share This Article